Mitomycine Substipharm 20 mg Filter Update for Injection Administration

Wed, 01 Apr 2026 18:19:20 +0000
Pharmaceuticals

ANSM issued an updated safety notice for Mitomycine Substipharm 20 mg, permanently including a Millex HV filter (0.45 μm / PVDF) with reconstitution vials. The agency clarified that filtration remains mandatory for intravenous, intra-arterial, and intra-serous administration but is no longer required for intravesical administration. Healthcare professionals in urology, oncology, and related specialties should update their administration protocols accordingly.